메뉴 건너뛰기




Volumn 42, Issue 4, 2015, Pages 493-505

Epidemiology and Management of Emerging Drug-Resistant Gram-Negative Bacteria: Extended-Spectrum β-Lactamases and Beyond

Author keywords

Antibiotic resistance; Carbapenem resistant Acinetobacter baumannii; Carbapenem resistant enterobacteriaceae; Extended spectrum lactamases; Multidrug resistant Pseudomonas aeruginosa; New Delhi metallo lactamase

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE; AMPICILLIN; AZTREONAM; BETA LACTAM ANTIBIOTIC; CARBAPENEM; CARBAPENEM DERIVATIVE; CEFEPIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN; CIPROFLOXACIN; COLISTIN; FOSFOMYCIN; GENTAMICIN; LEVOFLOXACIN; MINOCYCLINE; MONOBACTAM DERIVATIVE; NITROFURANTOIN; PIPERACILLIN PLUS TAZOBACTAM; POLYMYXIN; POLYMYXIN B; QUINOLONE DERIVATIVE; SULFONAMIDE; TETRACYCLINE DERIVATIVE; TIGECYCLINE; UNINDEXED DRUG; ANTIINFECTIVE AGENT; BACTERIAL PROTEIN; BETA LACTAMASE; CARBAPENEMASE;

EID: 84944679126     PISSN: 00940143     EISSN: 1558318X     Source Type: Journal    
DOI: 10.1016/j.ucl.2015.05.005     Document Type: Review
Times cited : (31)

References (67)
  • 1
    • 84887627398 scopus 로고    scopus 로고
    • Antibiotic resistance-the need for global solutions
    • Laxminarayan R., Duse A., Wattal C., et al. Antibiotic resistance-the need for global solutions. Lancet Infect Dis 2013, 13(12):1057-1098.
    • (2013) Lancet Infect Dis , vol.13 , Issue.12 , pp. 1057-1098
    • Laxminarayan, R.1    Duse, A.2    Wattal, C.3
  • 2
    • 84944700095 scopus 로고    scopus 로고
    • Accessed April 1
    • Available at:. Accessed April 1, 2015. http://www.cdc.gov/drugresistance/index.html.
    • (2015)
  • 3
    • 27144490073 scopus 로고    scopus 로고
    • Extended-spectrum beta-lactamases: a clinical update
    • Paterson D.L., Bonomo R.A. Extended-spectrum beta-lactamases: a clinical update. Clin Microbiol Rev 2005, 18(4):657-686.
    • (2005) Clin Microbiol Rev , vol.18 , Issue.4 , pp. 657-686
    • Paterson, D.L.1    Bonomo, R.A.2
  • 4
    • 39049128343 scopus 로고    scopus 로고
    • Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern
    • Pitout J.D., Laupland K.B. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166.
    • (2008) Lancet Infect Dis , vol.8 , Issue.3 , pp. 159-166
    • Pitout, J.D.1    Laupland, K.B.2
  • 5
    • 0021024916 scopus 로고
    • Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens
    • Knothe H., Shah P., Krcmery V., et al. Transferable resistance to cefotaxime, cefoxitin, cefamandole and cefuroxime in clinical isolates of Klebsiella pneumoniae and Serratia marcescens. Infection 1983, 11(6):315-317.
    • (1983) Infection , vol.11 , Issue.6 , pp. 315-317
    • Knothe, H.1    Shah, P.2    Krcmery, V.3
  • 6
    • 0023690533 scopus 로고
    • Broad-spectrum, transmissible beta-lactamases
    • Jacoby G.A., Medeiros A.A., O'Brien T.F., et al. Broad-spectrum, transmissible beta-lactamases. N Engl J Med 1988, 319(11):723-724.
    • (1988) N Engl J Med , vol.319 , Issue.11 , pp. 723-724
    • Jacoby, G.A.1    Medeiros, A.A.2    O'Brien, T.F.3
  • 7
    • 19944434187 scopus 로고    scopus 로고
    • The new beta-lactamases
    • Jacoby G.A., Munoz-Price L.S. The new beta-lactamases. N Engl J Med 2005, 352(4):380-391.
    • (2005) N Engl J Med , vol.352 , Issue.4 , pp. 380-391
    • Jacoby, G.A.1    Munoz-Price, L.S.2
  • 8
    • 84884650083 scopus 로고    scopus 로고
    • Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, the Netherlands and Germany
    • Wu G., Day M.J., Mafura M.T., et al. Comparative analysis of ESBL-positive Escherichia coli isolates from animals and humans from the UK, the Netherlands and Germany. PLoS One 2013, 8(9):e75392.
    • (2013) PLoS One , vol.8 , Issue.9 , pp. e75392
    • Wu, G.1    Day, M.J.2    Mafura, M.T.3
  • 9
    • 73949121686 scopus 로고    scopus 로고
    • Food reservoir for Escherichia coli causing urinary tract infections
    • Vincent C., Boerlin P., Daignault D., et al. Food reservoir for Escherichia coli causing urinary tract infections. Emerg Infect Dis 2010, 16(1):88-95.
    • (2010) Emerg Infect Dis , vol.16 , Issue.1 , pp. 88-95
    • Vincent, C.1    Boerlin, P.2    Daignault, D.3
  • 10
    • 84861210836 scopus 로고    scopus 로고
    • ESBL-positive Enterobacteria isolates in drinking water
    • De Boeck H., Miwanda B., Lunguya-Metila O., et al. ESBL-positive Enterobacteria isolates in drinking water. Emerg Infect Dis 2012, 18(6):1019-1020.
    • (2012) Emerg Infect Dis , vol.18 , Issue.6 , pp. 1019-1020
    • De Boeck, H.1    Miwanda, B.2    Lunguya-Metila, O.3
  • 11
    • 79951529601 scopus 로고    scopus 로고
    • Isolation of fluoroquinolone-resistant O25b:H4-ST131 Escherichia coli with CTX-M-14 extended-spectrum beta-lactamase from UK river water
    • Dhanji H., Murphy N.M., Akhigbe C., et al. Isolation of fluoroquinolone-resistant O25b:H4-ST131 Escherichia coli with CTX-M-14 extended-spectrum beta-lactamase from UK river water. J Antimicrob Chemother 2011, 66(3):512-516.
    • (2011) J Antimicrob Chemother , vol.66 , Issue.3 , pp. 512-516
    • Dhanji, H.1    Murphy, N.M.2    Akhigbe, C.3
  • 12
    • 70449631445 scopus 로고    scopus 로고
    • Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household
    • Johnson J.R., Miller S., Johnston B., et al. Sharing of Escherichia coli sequence type ST131 and other multidrug-resistant and Urovirulent E. coli strains among dogs and cats within a household. J Clin Microbiol 2009, 47(11):3721-3725.
    • (2009) J Clin Microbiol , vol.47 , Issue.11 , pp. 3721-3725
    • Johnson, J.R.1    Miller, S.2    Johnston, B.3
  • 13
    • 0035873724 scopus 로고    scopus 로고
    • Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region
    • Winokur P.L., Canton R., Casellas J.M., et al. Variations in the prevalence of strains expressing an extended-spectrum beta-lactamase phenotype and characterization of isolates from Europe, the Americas, and the Western Pacific region. Clin Infect Dis 2001, 32(Suppl 2):S94-S103.
    • (2001) Clin Infect Dis , vol.32 , pp. S94-S103
    • Winokur, P.L.1    Canton, R.2    Casellas, J.M.3
  • 14
    • 70149090868 scopus 로고    scopus 로고
    • A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients
    • Ben-Ami R., Rodríguez-Baño J., Arslan H., et al. A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. Clin Infect Dis 2009, 49(5):682-690.
    • (2009) Clin Infect Dis , vol.49 , Issue.5 , pp. 682-690
    • Ben-Ami, R.1    Rodríguez-Baño, J.2    Arslan, H.3
  • 15
    • 84862573595 scopus 로고    scopus 로고
    • Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli
    • Chopra T., Marchaim D., Veltman J., et al. Impact of cefepime therapy on mortality among patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Klebsiella pneumoniae and Escherichia coli. Antimicrob Agents Chemother 2012, 56(7):3936-3942.
    • (2012) Antimicrob Agents Chemother , vol.56 , Issue.7 , pp. 3936-3942
    • Chopra, T.1    Marchaim, D.2    Veltman, J.3
  • 16
    • 10744230588 scopus 로고    scopus 로고
    • Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study
    • Zanetti G., Bally F., Greub G., et al. Cefepime versus imipenem-cilastatin for treatment of nosocomial pneumonia in intensive care unit patients: a multicenter, evaluator-blind, prospective, randomized study. Antimicrob Agents Chemother 2003, 47(11):3442-3447.
    • (2003) Antimicrob Agents Chemother , vol.47 , Issue.11 , pp. 3442-3447
    • Zanetti, G.1    Bally, F.2    Greub, G.3
  • 17
    • 33744483523 scopus 로고    scopus 로고
    • Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species
    • Gavin P.J., Suseno M.T., Thomson R.B., et al. Clinical correlation of the CLSI susceptibility breakpoint for piperacillin- tazobactam against extended-spectrum-beta-lactamase-producing Escherichia coli and Klebsiella species. Antimicrob Agents Chemother 2006, 50(6):2244-2247.
    • (2006) Antimicrob Agents Chemother , vol.50 , Issue.6 , pp. 2244-2247
    • Gavin, P.J.1    Suseno, M.T.2    Thomson, R.B.3
  • 18
    • 0037282428 scopus 로고    scopus 로고
    • Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment
    • Rupp M.E., Fey P.D. Extended spectrum beta-lactamase (ESBL)-producing Enterobacteriaceae: considerations for diagnosis, prevention and drug treatment. Drugs 2003, 63(4):353-365.
    • (2003) Drugs , vol.63 , Issue.4 , pp. 353-365
    • Rupp, M.E.1    Fey, P.D.2
  • 19
    • 84869489961 scopus 로고    scopus 로고
    • Nitrofurantoin in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infection
    • Tasbakan M.I., Pullukcu H., Sipahi O.R., et al. Nitrofurantoin in the treatment of extended-spectrum beta-lactamase-producing Escherichia coli-related lower urinary tract infection. Int J Antimicrob Agents 2012, 40(6):554-556.
    • (2012) Int J Antimicrob Agents , vol.40 , Issue.6 , pp. 554-556
    • Tasbakan, M.I.1    Pullukcu, H.2    Sipahi, O.R.3
  • 20
    • 72149117149 scopus 로고    scopus 로고
    • Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review
    • Falagas M.E., Kastoris A.C., Kapaskelis A.M., et al. Fosfomycin for the treatment of multidrug-resistant, including extended-spectrum beta-lactamase producing, Enterobacteriaceae infections: a systematic review. Lancet Infect Dis 2010, 10(1):43-50.
    • (2010) Lancet Infect Dis , vol.10 , Issue.1 , pp. 43-50
    • Falagas, M.E.1    Kastoris, A.C.2    Kapaskelis, A.M.3
  • 21
    • 84861109391 scopus 로고    scopus 로고
    • Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis
    • Rottier W.C., Ammerlaan H.S., Bonten M.J., et al. Effects of confounders and intermediates on the association of bacteraemia caused by extended-spectrum beta-lactamase-producing Enterobacteriaceae and patient outcome: a meta-analysis. J Antimicrob Chemother 2012, 67(6):1311-1320.
    • (2012) J Antimicrob Chemother , vol.67 , Issue.6 , pp. 1311-1320
    • Rottier, W.C.1    Ammerlaan, H.S.2    Bonten, M.J.3
  • 22
    • 35348821803 scopus 로고    scopus 로고
    • A step closer to extreme drug resistance (XDR) in gram-negative bacilli
    • Paterson D.L., Doi Y. A step closer to extreme drug resistance (XDR) in gram-negative bacilli. Clin Infect Dis 2007, 45(9):1179-1181.
    • (2007) Clin Infect Dis , vol.45 , Issue.9 , pp. 1179-1181
    • Paterson, D.L.1    Doi, Y.2
  • 23
    • 24044518439 scopus 로고    scopus 로고
    • Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents
    • Bratu S., Tolaney P., Karumudi U., et al. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother 2005, 56(1):128-132.
    • (2005) J Antimicrob Chemother , vol.56 , Issue.1 , pp. 128-132
    • Bratu, S.1    Tolaney, P.2    Karumudi, U.3
  • 24
    • 34547422759 scopus 로고    scopus 로고
    • Carbapenemases: the versatile beta-lactamases
    • table of contents
    • Queenan A.M., Bush K. Carbapenemases: the versatile beta-lactamases. Clin Microbiol Rev 2007, 20(3):440-458. table of contents.
    • (2007) Clin Microbiol Rev , vol.20 , Issue.3 , pp. 440-458
    • Queenan, A.M.1    Bush, K.2
  • 25
    • 79951829390 scopus 로고    scopus 로고
    • Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase
    • Sidjabat H., Nimmo G.R., Walsh T.R., et al. Carbapenem resistance in Klebsiella pneumoniae due to the New Delhi Metallo-beta-lactamase. Clin Infect Dis 2011, 52(4):481-484.
    • (2011) Clin Infect Dis , vol.52 , Issue.4 , pp. 481-484
    • Sidjabat, H.1    Nimmo, G.R.2    Walsh, T.R.3
  • 26
    • 84875181975 scopus 로고    scopus 로고
    • Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance
    • Johnson A.P., Woodford N. Global spread of antibiotic resistance: the example of New Delhi metallo-beta-lactamase (NDM)-mediated carbapenem resistance. J Med Microbiol 2013, 62(Pt 4):499-513.
    • (2013) J Med Microbiol , vol.62 , pp. 499-513
    • Johnson, A.P.1    Woodford, N.2
  • 27
    • 0035084032 scopus 로고    scopus 로고
    • Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae
    • Yigit H., Queenan A.M., Anderson G.J., et al. Novel carbapenem-hydrolyzing beta-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother 2001, 45(4):1151-1161.
    • (2001) Antimicrob Agents Chemother , vol.45 , Issue.4 , pp. 1151-1161
    • Yigit, H.1    Queenan, A.M.2    Anderson, G.J.3
  • 28
    • 84876339272 scopus 로고    scopus 로고
    • "Nightmare" bacteria on the rise in US hospitals, long-term care facilities
    • Kuehn B.M. "Nightmare" bacteria on the rise in US hospitals, long-term care facilities. JAMA 2013, 309(15):1573-1574.
    • (2013) JAMA , vol.309 , Issue.15 , pp. 1573-1574
    • Kuehn, B.M.1
  • 29
    • 84870946642 scopus 로고    scopus 로고
    • Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010
    • Sievert D.M., Ricks P., Edwards J.R., et al. Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2009-2010. Infect Control Hosp Epidemiol 2013, 34(1):1-14.
    • (2013) Infect Control Hosp Epidemiol , vol.34 , Issue.1 , pp. 1-14
    • Sievert, D.M.1    Ricks, P.2    Edwards, J.R.3
  • 30
    • 84930486688 scopus 로고    scopus 로고
    • Global spread of carbapenemase-producing enterobacteriaceae
    • Nordmann P., Naas T., Poirel L., et al. Global spread of carbapenemase-producing enterobacteriaceae. Emerg Infect Dis 2011, 17(10):1791-1798.
    • (2011) Emerg Infect Dis , vol.17 , Issue.10 , pp. 1791-1798
    • Nordmann, P.1    Naas, T.2    Poirel, L.3
  • 31
    • 40549126250 scopus 로고    scopus 로고
    • Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality
    • Schwaber M.J., Klarfeld-Lidji S., Navon-Venezia S., et al. Predictors of carbapenem-resistant Klebsiella pneumoniae acquisition among hospitalized adults and effect of acquisition on mortality. Antimicrob Agents Chemother 2008, 52(3):1028-1033.
    • (2008) Antimicrob Agents Chemother , vol.52 , Issue.3 , pp. 1028-1033
    • Schwaber, M.J.1    Klarfeld-Lidji, S.2    Navon-Venezia, S.3
  • 32
    • 56749155916 scopus 로고    scopus 로고
    • Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies
    • Patel G., Huprikar S., Factor S.H., et al. Outcomes of carbapenem-resistant Klebsiella pneumoniae infection and the impact of antimicrobial and adjunctive therapies. Infect Control Hosp Epidemiol 2008, 29(12):1099-1106.
    • (2008) Infect Control Hosp Epidemiol , vol.29 , Issue.12 , pp. 1099-1106
    • Patel, G.1    Huprikar, S.2    Factor, S.H.3
  • 33
    • 84874894245 scopus 로고    scopus 로고
    • Vital signs: carbapenem-resistant Enterobacteriaceae
    • Centers for Disease Control and Prevention (CDC) Vital signs: carbapenem-resistant Enterobacteriaceae. MMWR Morb Mortal Wkly Rep 2013, 62(9):165-170.
    • (2013) MMWR Morb Mortal Wkly Rep , vol.62 , Issue.9 , pp. 165-170
  • 34
    • 80052247996 scopus 로고    scopus 로고
    • Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae
    • Won S.Y., Munoz-Price L.S., Lolans K., et al. Emergence and rapid regional spread of Klebsiella pneumoniae carbapenemase-producing Enterobacteriaceae. Clin Infect Dis 2011, 53(6):532-540.
    • (2011) Clin Infect Dis , vol.53 , Issue.6 , pp. 532-540
    • Won, S.Y.1    Munoz-Price, L.S.2    Lolans, K.3
  • 35
    • 84865323065 scopus 로고    scopus 로고
    • Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing
    • Snitkin E.S., Zelazny A.M., Thomas P.J., et al. Tracking a hospital outbreak of carbapenem-resistant Klebsiella pneumoniae with whole-genome sequencing. Sci Transl Med 2012, 4(148):148ra116.
    • (2012) Sci Transl Med , vol.4 , Issue.148 , pp. 148ra116
    • Snitkin, E.S.1    Zelazny, A.M.2    Thomas, P.J.3
  • 36
    • 84862146733 scopus 로고    scopus 로고
    • Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort
    • Alexander B.T., Marschall J., Tibbetts R.J., et al. Treatment and clinical outcomes of urinary tract infections caused by KPC-producing Enterobacteriaceae in a retrospective cohort. Clin Ther 2012, 34(6):1314-1323.
    • (2012) Clin Ther , vol.34 , Issue.6 , pp. 1314-1323
    • Alexander, B.T.1    Marschall, J.2    Tibbetts, R.J.3
  • 37
    • 84866072596 scopus 로고    scopus 로고
    • Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy
    • Tumbarello M., Viale P., Viscoli C., et al. Predictors of mortality in bloodstream infections caused by Klebsiella pneumoniae carbapenemase-producing K. pneumoniae: importance of combination therapy. Clin Infect Dis 2012, 55(7):943-950.
    • (2012) Clin Infect Dis , vol.55 , Issue.7 , pp. 943-950
    • Tumbarello, M.1    Viale, P.2    Viscoli, C.3
  • 38
    • 83655201460 scopus 로고    scopus 로고
    • Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections
    • Ben-David D., Kordevani R., Keller N., et al. Outcome of carbapenem resistant Klebsiella pneumoniae bloodstream infections. Clin Microbiol Infect 2012, 18(1):54-60.
    • (2012) Clin Microbiol Infect , vol.18 , Issue.1 , pp. 54-60
    • Ben-David, D.1    Kordevani, R.2    Keller, N.3
  • 39
    • 80054088449 scopus 로고    scopus 로고
    • Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system
    • Pogue J.M., Lee J., Marchaim D., et al. Incidence of and risk factors for colistin-associated nephrotoxicity in a large academic health system. Clin Infect Dis 2011, 53(9):879-884.
    • (2011) Clin Infect Dis , vol.53 , Issue.9 , pp. 879-884
    • Pogue, J.M.1    Lee, J.2    Marchaim, D.3
  • 40
    • 0021348796 scopus 로고
    • Risk factors for nephrotoxicity in patients treated with aminoglycosides
    • Moore R.D., Smith C.R., Lipsky J.J., et al. Risk factors for nephrotoxicity in patients treated with aminoglycosides. Ann Intern Med 1984, 100(3):352-357.
    • (1984) Ann Intern Med , vol.100 , Issue.3 , pp. 352-357
    • Moore, R.D.1    Smith, C.R.2    Lipsky, J.J.3
  • 41
    • 84875971014 scopus 로고    scopus 로고
    • The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia
    • Molton J.S., Tambyah P.A., Ang B.S., et al. The global spread of healthcare-associated multidrug-resistant bacteria: a perspective from Asia. Clin Infect Dis 2013, 56(9):1310-1318.
    • (2013) Clin Infect Dis , vol.56 , Issue.9 , pp. 1310-1318
    • Molton, J.S.1    Tambyah, P.A.2    Ang, B.S.3
  • 42
    • 84907690490 scopus 로고    scopus 로고
    • New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes
    • Epstein L., Hunter J.C., Arwady M.A., et al. New Delhi metallo-beta-lactamase-producing carbapenem-resistant Escherichia coli associated with exposure to duodenoscopes. JAMA 2014, 312(14):1447-1455.
    • (2014) JAMA , vol.312 , Issue.14 , pp. 1447-1455
    • Epstein, L.1    Hunter, J.C.2    Arwady, M.A.3
  • 43
    • 56049089389 scopus 로고    scopus 로고
    • Current control and treatment of multidrug-resistant Acinetobacter baumannii infections
    • Karageorgopoulos D.E., Falagas M.E. Current control and treatment of multidrug-resistant Acinetobacter baumannii infections. Lancet Infect Dis 2008, 8(12):751-762.
    • (2008) Lancet Infect Dis , vol.8 , Issue.12 , pp. 751-762
    • Karageorgopoulos, D.E.1    Falagas, M.E.2
  • 44
    • 36248932659 scopus 로고    scopus 로고
    • An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii
    • Dijkshoorn L., Nemec A., Seifert H., et al. An increasing threat in hospitals: multidrug-resistant Acinetobacter baumannii. Nat Rev Microbiol 2007, 5(12):939-951.
    • (2007) Nat Rev Microbiol , vol.5 , Issue.12 , pp. 939-951
    • Dijkshoorn, L.1    Nemec, A.2    Seifert, H.3
  • 45
    • 33747625237 scopus 로고    scopus 로고
    • Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa
    • Bonomo R.A., Szabo D. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa. Clin Infect Dis 2006, 43(Suppl 2):S49-S56.
    • (2006) Clin Infect Dis , vol.43 , pp. S49-S56
    • Bonomo, R.A.1    Szabo, D.2
  • 46
    • 0030856704 scopus 로고    scopus 로고
    • Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods
    • Seifert H., Dijkshoorn L., Gerner-Smidt P., et al. Distribution of Acinetobacter species on human skin: comparison of phenotypic and genotypic identification methods. J Clin Microbiol 1997, 35(11):2819-2825.
    • (1997) J Clin Microbiol , vol.35 , Issue.11 , pp. 2819-2825
    • Seifert, H.1    Dijkshoorn, L.2    Gerner-Smidt, P.3
  • 47
    • 0032811295 scopus 로고    scopus 로고
    • Skin carriage of acinetobacters in Hong Kong
    • Chu Y.W., Leung C.M., Houang E.T., et al. Skin carriage of acinetobacters in Hong Kong. J Clin Microbiol 1999, 37(9):2962-2967.
    • (1999) J Clin Microbiol , vol.37 , Issue.9 , pp. 2962-2967
    • Chu, Y.W.1    Leung, C.M.2    Houang, E.T.3
  • 49
    • 33847027647 scopus 로고    scopus 로고
    • Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences
    • Playford E.G., Craig J.C., Iredell J.R., et al. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 2007, 65(3):204-211.
    • (2007) J Hosp Infect , vol.65 , Issue.3 , pp. 204-211
    • Playford, E.G.1    Craig, J.C.2    Iredell, J.R.3
  • 50
    • 33144460009 scopus 로고    scopus 로고
    • The epidemiology and control of Acinetobacter baumannii in health care facilities
    • Fournier P.E., Richet H. The epidemiology and control of Acinetobacter baumannii in health care facilities. Clin Infect Dis 2006, 42(5):692-699.
    • (2006) Clin Infect Dis , vol.42 , Issue.5 , pp. 692-699
    • Fournier, P.E.1    Richet, H.2
  • 51
    • 34249909267 scopus 로고    scopus 로고
    • An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq
    • Scott P., Deye G., Srinivasan A., et al. An outbreak of multidrug-resistant Acinetobacter baumannii-calcoaceticus complex infection in the US military health care system associated with military operations in Iraq. Clin Infect Dis 2007, 44(12):1577-1584.
    • (2007) Clin Infect Dis , vol.44 , Issue.12 , pp. 1577-1584
    • Scott, P.1    Deye, G.2    Srinivasan, A.3
  • 52
    • 35448962165 scopus 로고    scopus 로고
    • Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline
    • Reinert R.R., Low D.E., Rossi F., et al. Antimicrobial susceptibility among organisms from the Asia/Pacific Rim, Europe and Latin and North America collected as part of TEST and the in vitro activity of tigecycline. J Antimicrob Chemother 2007, 60(5):1018-1029.
    • (2007) J Antimicrob Chemother , vol.60 , Issue.5 , pp. 1018-1029
    • Reinert, R.R.1    Low, D.E.2    Rossi, F.3
  • 53
    • 84955747361 scopus 로고    scopus 로고
    • Treatment of carbapenem-resistant acinetobacter baumannii ventilator-associated pneumonia: retrospective comparison between intravenous colistin and intravenous ampicillin-sulbactam
    • [Epub ahead of print]
    • Zalts R., Neuberger A., Hussein K., et al. Treatment of carbapenem-resistant acinetobacter baumannii ventilator-associated pneumonia: retrospective comparison between intravenous colistin and intravenous ampicillin-sulbactam. Am J Ther 2013, [Epub ahead of print].
    • (2013) Am J Ther
    • Zalts, R.1    Neuberger, A.2    Hussein, K.3
  • 54
    • 77957882351 scopus 로고    scopus 로고
    • Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak
    • Munoz-Price L.S., Zembower T., Penugonda S., et al. Clinical outcomes of carbapenem-resistant Acinetobacter baumannii bloodstream infections: study of a 2-state monoclonal outbreak. Infect Control Hosp Epidemiol 2010, 31(10):1057-1062.
    • (2010) Infect Control Hosp Epidemiol , vol.31 , Issue.10 , pp. 1057-1062
    • Munoz-Price, L.S.1    Zembower, T.2    Penugonda, S.3
  • 55
    • 3943093972 scopus 로고    scopus 로고
    • Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study
    • Wisplinghoff H., Bischoff T., Tallent S.M., et al. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004, 39(3):309-317.
    • (2004) Clin Infect Dis , vol.39 , Issue.3 , pp. 309-317
    • Wisplinghoff, H.1    Bischoff, T.2    Tallent, S.M.3
  • 56
    • 33746093374 scopus 로고    scopus 로고
    • Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies
    • Falagas M.E., Bliziotis I.A., Siempos, et al. Attributable mortality of Acinetobacter baumannii infections in critically ill patients: a systematic review of matched cohort and case-control studies. Crit Care 2006, 10(2):R48.
    • (2006) Crit Care , vol.10 , Issue.2 , pp. R48
    • Falagas, M.E.1    Bliziotis, I.A.2    Siempos3
  • 57
    • 0037352118 scopus 로고    scopus 로고
    • Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study
    • Blot S., Vandewoude K., Colardyn F., et al. Nosocomial bacteremia involving Acinetobacter baumannii in critically ill patients: a matched cohort study. Intensive Care Med 2003, 29(3):471-475.
    • (2003) Intensive Care Med , vol.29 , Issue.3 , pp. 471-475
    • Blot, S.1    Vandewoude, K.2    Colardyn, F.3
  • 58
    • 70449124604 scopus 로고    scopus 로고
    • Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms
    • Lister P.D., Wolter D.J., Hanson N.D., et al. Antibacterial-resistant Pseudomonas aeruginosa: clinical impact and complex regulation of chromosomally encoded resistance mechanisms. Clin Microbiol Rev 2009, 22(4):582-610.
    • (2009) Clin Microbiol Rev , vol.22 , Issue.4 , pp. 582-610
    • Lister, P.D.1    Wolter, D.J.2    Hanson, N.D.3
  • 59
    • 84857646835 scopus 로고    scopus 로고
    • Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance
    • Magiorakos A.P., Srinivasan A., Carey R.B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect 2012, 18(3):268-281.
    • (2012) Clin Microbiol Infect , vol.18 , Issue.3 , pp. 268-281
    • Magiorakos, A.P.1    Srinivasan, A.2    Carey, R.B.3
  • 60
    • 0021491688 scopus 로고
    • Epidemiology of infections due to Pseudomonas aeruginosa
    • Morrison A.J., Wenzel R.P. Epidemiology of infections due to Pseudomonas aeruginosa. Rev Infect Dis 1984, 6(Suppl 3):S627-S642.
    • (1984) Rev Infect Dis , vol.6 , pp. S627-S642
    • Morrison, A.J.1    Wenzel, R.P.2
  • 61
    • 84873092022 scopus 로고    scopus 로고
    • Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa
    • Nakamura A., Miyake K., Misawa S., et al. Meropenem as predictive risk factor for isolation of multidrug-resistant Pseudomonas aeruginosa. J Hosp Infect 2013, 83(2):153-155.
    • (2013) J Hosp Infect , vol.83 , Issue.2 , pp. 153-155
    • Nakamura, A.1    Miyake, K.2    Misawa, S.3
  • 62
    • 29944446141 scopus 로고    scopus 로고
    • Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact
    • Aloush V., Navon-Venezia S., Seigman-Igra Y., et al. Multidrug-resistant Pseudomonas aeruginosa: risk factors and clinical impact. Antimicrob Agents Chemother 2006, 50(1):43-48.
    • (2006) Antimicrob Agents Chemother , vol.50 , Issue.1 , pp. 43-48
    • Aloush, V.1    Navon-Venezia, S.2    Seigman-Igra, Y.3
  • 63
    • 0036677948 scopus 로고    scopus 로고
    • An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit
    • Bukholm G., Tannaes T., Kjelsberg A.B., et al. An outbreak of multidrug-resistant Pseudomonas aeruginosa associated with increased risk of patient death in an intensive care unit. Infect Control Hosp Epidemiol 2002, 23(8):441-446.
    • (2002) Infect Control Hosp Epidemiol , vol.23 , Issue.8 , pp. 441-446
    • Bukholm, G.1    Tannaes, T.2    Kjelsberg, A.B.3
  • 64
    • 71549131283 scopus 로고    scopus 로고
    • Pseudomonas aeruginosa: a formidable and ever-present adversary
    • Kerr K.G., Snelling A.M. Pseudomonas aeruginosa: a formidable and ever-present adversary. J Hosp Infect 2009, 73(4):338-344.
    • (2009) J Hosp Infect , vol.73 , Issue.4 , pp. 338-344
    • Kerr, K.G.1    Snelling, A.M.2
  • 65
    • 77956104810 scopus 로고    scopus 로고
    • Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes
    • Tam V.H., Rogers C.A., Chang K.T., et al. Impact of multidrug-resistant Pseudomonas aeruginosa bacteremia on patient outcomes. Antimicrob Agents Chemother 2010, 54(9):3717-3722.
    • (2010) Antimicrob Agents Chemother , vol.54 , Issue.9 , pp. 3717-3722
    • Tam, V.H.1    Rogers, C.A.2    Chang, K.T.3
  • 66
    • 84944700096 scopus 로고    scopus 로고
    • Accessed April 1
    • Available at:. Accessed April 1, 2015. http://www.cdc.gov/drugresistance/pdf/ar-threats-2013-508.pdf.
    • (2015)
  • 67
    • 79953874331 scopus 로고    scopus 로고
    • Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections
    • Dortch M.J., Fleming S.B., Kauffmann R.M., et al. Infection reduction strategies including antibiotic stewardship protocols in surgical and trauma intensive care units are associated with reduced resistant gram-negative healthcare-associated infections. Surg Infect (Larchmt) 2011, 12(1):15-25.
    • (2011) Surg Infect (Larchmt) , vol.12 , Issue.1 , pp. 15-25
    • Dortch, M.J.1    Fleming, S.B.2    Kauffmann, R.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.